IgG4とは 意味・読み方・使い方

To provide a method for identifying a pathognomonic marker of an IgG4-related disease, distinguishing an IgG4-related disease from similar diseases, and simply diagnosing an IgG4-related disease, to elucidate the cause of disease and pathologic condition of IgG4-related disease on the basis of the marker, to establish a disease concept and to provide diagnostic criteria of IgG4-related disease.例文帳に追加

IgG4関連疾患の特徴的マーカーを同定し、IgG4関連疾患を類似する疾患と区別して簡便に診断する方法、並びに、前記マーカーに基づきIgG4関連疾患の病因病態を解明し、疾患概念の確立して、IgG4関連疾患の診断基準を提供する。 - 特許庁

MARKER FOR DIAGNOSING IgG4-RELATED DISEASE AND APPLICATION THEREOF例文帳に追加

ＩｇＧ４関連疾患診断用マーカー及びその利用 - 特許庁

The present invention also relates to pharmaceutical compositions comprising chimerized anti-CD19 antibodies of the IgG1, IgG2, IgG3, or IgG4 isotype that mediate human ADCC.例文帳に追加

また、ヒトＡＤＣＣを媒介する、ＩｇＧ１、ＩｇＧ２、ＩｇＧ３またはＩｇＧ４アイソタイプのキメラ化抗ＣＤ１９抗体を含む薬学的組成物。 - 特許庁

The present invention relates to pharmaceutical compositions comprising human or humanized anti-CD19 antibodies of the IgG2 or IgG4 human isotype that preferably mediate human ADCC.例文帳に追加

好ましくはヒトＡＤＣＣを媒介する、ＩｇＧ２またはＩｇＧ４ヒトアイソタイプのヒト抗ＣＤ１９抗体またはヒト化抗ＣＤ１９抗体を含む薬学的組成物。 - 特許庁

The method for evaluating an affection or pathologic condition of an IgG4-related disease of a subject is based on an expression amount of one or more genes selected from a specific group in a specimen isolated from the subject or an expression amount of at least one or more proteins selected from the group consisting of protein symbol CLUS, ALTA, PEDF, DCD, and SAA4.例文帳に追加

被験者から単離された検体における、特定の遺伝子群から選ばれる少なくとも１以上の遺伝子の発現量、あるいは蛋白質シンボルCLUS、ALTA、PEDF、DCD、及びSAA4からなる群から選ばれる少なくとも１以上の蛋白質の発現量に基づき、当該被験者のIgG4関連疾患の罹患あるいは病態を評価する方法。 - 特許庁

This medicinal composition contains, as an active ingredient, EBV genome negative antibodies (TT1+TT2) including the two subtypes IgG1, IgG4 of a perfect human antibody produced by a perfect human antibody-producing hybridoma obtained by fusing a fused myeloma cell selected and obtained it as an index to be negative to EBV genome, with an EBV transformed human cell B which produces an antibody to a certain antibody.例文帳に追加

本発明の医薬組成物は、ＥＢＶゲノム陰性であることを指標に選抜されて得られた融合ミエローマ細胞と、ある抗原に対する抗体を産生するＥＢＶ形質転換ヒトＢ細胞と、を細胞融合して得られる完全ヒト抗体産生ハイブリドーマが産生する完全ヒト抗体のサブタイプＩｇＧ１、ＩｇＧ４の２種からなるＥＢＶゲノム陰性抗体（ＴＴ１＋ＴＴ２）を有効成分とする。 - 特許庁